Issued Patents All Time
Showing 1–11 of 11 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12201690 | Formulations/compositions comprising ibrutinib | Maristella Bernini, Wenyu Dong | 2025-01-21 |
| 11458134 | 1-[2-(2,4-dimeihylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment | Andre Faldt, Heidi Lopez de Diego, Michael J. Mealy | 2022-10-04 |
| 11279682 | Vortioxetine pyroglutamate | Heidi Lopez de Diego, Kim Lasse Christensen, Jens Kateb | 2022-03-22 |
| 10287261 | Vortioxetine pyroglutamate | Heidi Lopez de Diego, Kim Lasse Christensen, Jens Kateb | 2019-05-14 |
| 9861630 | 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment | Andre Faldt, Heidi Lopez de Diego | 2018-01-09 |
| 9610287 | Method of administration of 4-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and the salts thereof in the treatment of schizophrenia | Lone Bruun | 2017-04-04 |
| 9227946 | 1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1a activity for the treatment of cognitive impairment | Andre Faldt, Heidi Lopez de Diego | 2016-01-05 |
| 9125908 | 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment | Benny Bang-Andersen, Arne Mork, Tine Bryan Stensbol, Andre Faldt, Heidi Lopez de Diego | 2015-09-08 |
| 9125909 | 1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment | Benny Bang-Andersen, Andre Faldt, Arne Mork, Heidi Lopez de Diego, Tine Bryan Stensbol | 2015-09-08 |
| 8969355 | 1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1a activity for the treatment of cognitive impairment | Benny Bang-Andersen, Andre Faldt, Heidi Lopez de Diego | 2015-03-03 |
| 8722684 | 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment | Benny Bang-Andersen, Andre Faldt, Arne Mork, Heidi Lopez de Diego, Tine Bryan Stensbol +1 more | 2014-05-13 |